Clinical Trial Update: Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing sirolimus-eluting versus zotarolimus-eluting stents for chronic total occlusions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Stenosis

Drugs mentioned

• Sirolimus-eluting stent (sirolimus-eluting stent)
• Zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: R&D Cardiologie | Conditions: Coronary Artery Disease, Coronary Disease | Phase 3 | Status: COMPLETED